Evidence map›Paper›PMID 32821278›Full record

ArticleEvolutionary applications2020

Age-dependent expression of cancer-related genes in a long-lived seabird.

Richard Meitern, Jérôme Fort, Mathieu Giraudeau, Kalev Rattiste, Elin Sild, Tuul Sepp

Open access · goldAbstract read
In one paragraph

Article in Evolutionary applications, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
1.3field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Approaches and methods to study wildlife cancer.The Journal of animal ecology · 2024
    Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 2 countries.

Richard MeiternInstitute of Ecology and Earth Sciences University of Tartu Tartu Estonia.ORCID https://orcid.org/0000-0002-2600-3002
Jérôme FortLittoral Environnement et Sociétés (LIENSs) UMR 7266 CNRS-La Rochelle Université La Rochelle France.
Mathieu GiraudeauCREEC/CREES MIVEGEC, UMR IRD/CNRS/UM 5290 Montpellier France.
Kalev RattisteInstitute of Agricultural and Environmental Sciences Estonian University of Life Sciences Tartu Estonia.
Elin SildInstitute of Ecology and Earth Sciences University of Tartu Tartu Estonia.
Tuul SeppInstitute of Ecology and Earth Sciences University of Tartu Tartu Estonia.
University of Tartu · EECentre National de la Recherche Scientifique · FREstonian University of Life Sciences · EE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Studies of model animals like mice and rats have led to great advances in our understanding of the process of tumorigenesis, but this line of study has less to offer for understanding the mechanisms of cancer resistance. Increasing the diversity of nonmodel species from the perspective of molecular mechanisms of natural cancer resistance can lead to new insights into the evolution of protective mechanisms against neoplastic processes and to a wider understanding of natural cancer defense mechanisms. Such knowledge could then eventually be harnessed for the development of human cancer therapies. We suggest here that seabirds are promising, albeit currently completely ignored candidates for studying cancer defense mechanisms, as they have a longer maximum life span than expected from their body size and rates of energy metabolism and may have thus evolved mechanisms to limit neoplasia progression, especially at older ages. We here apply a novel, intraspecific approach of comparing old and young seabirds for improving our understanding of aging and neoplastic processes in natural settings. We used the long-lived common gulls (

Indexed as

cancer defensesgene expressionLarus canussenescencetranscriptomewild animals

Identifiers

PMID32821278
PMCPMC7428815
OpenAlexW3026845773

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.